Purchase Order 75F40123P00040
Award Date 3/9/23
Potential Completion Date 9/30/23
Potential Value $227K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for a MICROSEQ GENETIC ANALYZER. The $323,879.64 award does not have a set-aside designation and was made on August 24, 2017 with a completion date of August 23, 2021. As a division of Thermo Fisher Scientific, Life Technologies serves as a prime contractor across various federal...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, was awarded a firm fixed-price delivery order valued at $89,378.45 for an ION Genestudio S5 Prime Sequencer to support a civilian federal agency's Southeast Area operations in Miami, Florida. This contract, awarded on August 19, 2022, with a completion date of September 19, 2022, represents a non-competitive procurement with no set-aside designation. The ION Genestudio S5 Prime is a genetic sequencing instrument widely used in...
- The Department of Health and Human Services Food and Drug Administration awarded a $918,227.19 firm-fixed-price definitive contract to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the provision of genetic analyzers, warranty, and maintenance services. The contract has an April 26, 2024 completion date and was awarded on April 18, 2019 without the use of a set-aside. Life Technologies Corporation, a leading provider of biomedical research and genetic analysis...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $82,231.05 firm fixed-price purchase order by the Food and Drug Administration on August 15, 2022, for an Automated Express Nucleic Acid Extraction System (Part # 4467754). The contract was awarded without set-aside designation and has an ultimate completion date of October 14, 2027. The system will be delivered to the FDA's facility in Grand Island, New York. This award supports the FDA's regulatory...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $195,000 contract is for the upgrade of ABI software, with a completion date of September 25, 2023. Life Technologies has experience providing a range of genetic analysis and laboratory equipment products and services to support federal biomedical research, medical...
- The Food and Drug Administration (FDA) awarded a one-year, $32,507.04 Firm Fixed Price purchase order to Life Technologies Corporation for preventive maintenance and unlimited repair services on a Life Technologies ION GeneStudio S5 Prime System. This contract was competed on a full and open basis with no set-aside designation. Life Technologies Corporation is a manufacturer of scientific instruments, reagents, and consumables that provides products and services to support biomedical research,...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at seventy-six thousand three hundred fourteen dollars and thirteen cents ($76,314.13) to Life Technologies Corporation. Performance will take place in Carlsbad, California from August 25, 2023 through September 30, 2023. The award is in response to a solicitation for a QuantStudio 7 Pro Real-Time PCR system to support the agency's...
- The U.S. government awarded a delivery order valued at $64,752 to Life Technologies Corporation (operating as Thermo Fisher Scientific) on March 13, 2026, for the procurement of a Sanger Sequencer—SeqStudio with SmartStart system. The award is a firm fixed price delivery order with no set-aside designation, with an ultimate completion date of May 13, 2026. The equipment will be delivered to Athens, Georgia. Life Technologies Corporation is a leading manufacturer of scientific instruments,...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $73,873.01 firm fixed-price purchase order to Life Technologies Corporation for a QuantStudio Absolute Q Digital PCR System. The award was not set aside for any specific business size or type. Life Technologies Corporation is a subsidiary of the Thermo Electron Corporation, a for-profit manufacturer of scientific equipment and services. This contract appears to be a standalone award, as no larger...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $236,257.60 contract is for the delivery of products and services to support the agency's biomedical research, applied markets, and forensic analysis initiatives. Life Technologies has provided genetic...